Literature DB >> 33442396

Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis.

Wenjie Li1,2, Mengting Li1,2, Haizhou Wang1,2, Yanan Peng1,2, Shouquan Dong1,2, Yuanyuan Lu1,2, Fan Wang1,2, Fei Xu1,2, Lan Liu1,2, Qiu Zhao1,2.   

Abstract

Objective: Immune cells infiltrating has been proved to be associated with prognosis in gastric cancer (GC) by studies. This study aims to explore the prognosis value of infiltrating immune cells in gastric cancer.
Methods: In our study, the CIBERSORT algorithm was used to calculate the fraction of 22 tumor-infiltrating immune cells (TIIC) in 100 normal and 300 tumor samples from the GEO cohort and 30 normal and 344 tumor samples from the TCGA cohort. Univariate and multivariate Cox regression were used to construct an immune risk score model. Multivariate cox regression was also used to validate whether our risk score model could predict prognosis in GC independently. Furthermore, the model was validated in different patient subgroups to test its independence. P<0.05 was considered statistically significant.
Results: The results showed that the fraction of 3 immune cells increased in tumor tissues compared with normal tissues in both the GEO and TCGA cohort. Univariate cox regression analysis showed four cells significantly correlated with survival rate in GC (P<0.05). The immune risk score model was constructed based on the four cells through multivariate cox regression and further validated. The KM survival curve suggested that patients with high risk had poor prognosis than patients with low risk (P<0.05). ROC curve indicated the model was reliable (AUC= 0.67 in the GEO cohort, AUC = 0.65 in the TCGA cohort). Furthermore, multivariate Cox regression showed the model was an independent factor for overall survival predicting in GC (hazard ratio (HR) = 2.35, 95% confidence interval (CI) = 1.63~3.40 in the GEO cohort, HR = 2.87, 95% CI = 1.94~4.25 in the TCGA cohort). Finally, we validated the model in patient subgroups by the KM survival curve.
Conclusion: In summary, tumor-infiltrating immune cells play an essential role in GC progression and affect the outcome of GC patients. The immune risk score can predict overall survival for GC independently, and high immune risk score is associated with poor prognosis. © The author(s).

Entities:  

Keywords:  TIICs; gastric cancer; immune risk score model; multivariate cox regression; prognosis

Year:  2021        PMID: 33442396      PMCID: PMC7797666          DOI: 10.7150/jca.51079

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  37 in total

Review 1.  Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy.

Authors:  Yugang Wu; Liang Wang; Yanyun Zhang
Journal:  Cell Mol Immunol       Date:  2004-10       Impact factor: 11.530

2.  Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.

Authors:  Sung Hoon Noh; Sook Ryun Park; Han-Kwang Yang; Hyun Cheol Chung; Ik-Joo Chung; Sang-Woon Kim; Hyung-Ho Kim; Jin-Hyuk Choi; Hoon-Kyo Kim; Wansik Yu; Jong Inn Lee; Dong Bok Shin; Jiafu Ji; Jen-Shi Chen; Yunni Lim; Stella Ha; Yung-Jue Bang
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

3.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

Review 4.  The PD-1 pathway in tolerance and autoimmunity.

Authors:  Loise M Francisco; Peter T Sage; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

5.  Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jaffer A Ajani; Thomas A D'Amico; Khaldoun Almhanna; David J Bentrem; Joseph Chao; Prajnan Das; Crystal S Denlinger; Paul Fanta; Farhood Farjah; Charles S Fuchs; Hans Gerdes; Michael Gibson; Robert E Glasgow; James A Hayman; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Dawn Jaroszewski; Kimberly L Johung; Rajesh N Keswani; Lawrence R Kleinberg; W Michael Korn; Stephen Leong; Catherine Linn; A Craig Lockhart; Quan P Ly; Mary F Mulcahy; Mark B Orringer; Kyle A Perry; George A Poultsides; Walter J Scott; Vivian E Strong; Mary Kay Washington; Benny Weksler; Christopher G Willett; Cameron D Wright; Debra Zelman; Nicole McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2016-10       Impact factor: 11.908

6.  Fatty acid synthase is a prognostic marker and associated with immune infiltrating in gastric cancers precision medicine.

Authors:  Yangying Zhou; Weiping Su; Huan Liu; Taili Chen; Naseruddin Höti; Haiping Pei; Hong Zhu
Journal:  Biomark Med       Date:  2020-01-06       Impact factor: 2.851

7.  Identification of immune cells and mRNA associated with prognosis of gastric cancer.

Authors:  Mingming Wang; Zedong Li; Yu Peng; Jianyu Fang; Tao Fang; Jiajia Wu; Jun Zhou
Journal:  BMC Cancer       Date:  2020-03-12       Impact factor: 4.430

8.  Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer.

Authors:  Kai Liu; Kun Yang; Bin Wu; HaiNing Chen; XiaoLong Chen; XinZu Chen; LiLi Jiang; FuXiang Ye; Du He; ZhengHao Lu; Lian Xue; WeiHan Zhang; Qiu Li; ZongGuang Zhou; XianMing Mo; JianKun Hu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

9.  PD-L1 Expression and CD8+ T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer.

Authors:  Yangyang Wang; Chunchao Zhu; Wei Song; Jun Li; Gang Zhao; Hui Cao
Journal:  J Immunol Res       Date:  2018-05-29       Impact factor: 4.818

10.  High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer.

Authors:  Minyu Wang; Yu-Kuan Huang; Joseph Ch Kong; Yu Sun; Daniela G Tantalo; Han Xian Aw Yeang; Le Ying; Feng Yan; Dakang Xu; Heloise Halse; Natasha Di Costanzo; Ian R Gordon; Catherine Mitchell; Laura K Mackay; Rita A Busuttil; Paul J Neeson; Alex Boussioutas
Journal:  Clin Transl Immunology       Date:  2020-05-05
View more
  3 in total

1.  An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma.

Authors:  Xiaowen Zhao; Pingfan Wu; Dongling Liu; Changtian Li; Ling Xue; Zhe Liu; Meng Zhu; Jie Yang; Ziyi Chen; Yaling Li; Yali She
Journal:  J Healthc Eng       Date:  2022-04-25       Impact factor: 3.822

2.  Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.

Authors:  Chao Ma; Xin Zhang; Xudong Zhao; Nan Zhang; Sixin Zhou; Yonghui Zhang; Peiyu Li
Journal:  Front Genet       Date:  2021-09-06       Impact factor: 4.599

Review 3.  The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.

Authors:  Negar Hosseinkhani; Afshin Derakhshani; Mahdi Abdoli Shadbad; Antonella Argentiero; Vito Racanelli; Tohid Kazemi; Ahad Mokhtarzadeh; Oronzo Brunetti; Nicola Silvestris; Behzad Baradaran
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.